US firm Bot M.D. has received $700,000 in seed funding from Y Combinator and others for its AI-powered chatbot app, which helps doctors find relevant and more specialised information than would be served up by a search engine. The app is intended to support clinical decisions regarding drug interactions, medical calculations and information on less common diseases. In the US, there are currently no laws that require AI companies to disclose their source code or how they use it. To date it has been taken up in 52 countries and is available free on the Google Play store.
US firm Bot M.D. has received $700,000 in seed funding from Y Combinator and others for its AI-powered chatbot app, which helps doctors find relevant and more specialised information than would be served up by a search engine. The app is intended to support clinical decisions regarding drug interactions, medical calculations and information on less common diseases. The app also enables doctors to interact securely with each other and has transcription and dictation functions. To date it has been taken up in 52 countries and is available free on the Google Play store.